Unichem Laboratories Ltd.

Financial

	Unichem Lab	Dishman Carbogen Amc	Biocon
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	41.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	27.0 .	n/a	n/a
R&D as a % of Total Sales	0.94 %	2.89 %	8.32 %
Financials
5 yr Average ROE	-1.8 %	0.72 %	9.2 %
5yr average Equity Multiplier	1.25	1.49	2.34
5yr Average Asset Turnover Ratio	0.39	0.25	0.39
5yr Avg Net Profit Margin	-3.43 %	1.79 %	10.15 %
Price to Book	1.73	0.62	1.94
P/E	286.49	0.0	30.71
5yr Avg Cash Conversion Cycle	134.58 Days	42.6 Days	-81.57 Days
Inventory Days	136.89 Days	101.13 Days	82.47 Days
Days Receivable	147.31 Days	80.42 Days	91.14 Days
Days Payable	232.31 Days	166.8 Days	232.53 Days
5yr Average Interest Coverage Ratio	-1.13	2.31	15.21
5yr Avg ROCE	-1.02 %	2.38 %	9.08 %
5yr Avg Operating Profit Margin	5.06 %	20.95 %	27.02 %
5 yr average Debt to Equity	0.09	0.23	0.58
5yr CAGR Net Profit	53.41 %	n/a	-12.56 %
5yr Average Return on Assets	-1.39 %	0.54 %	4.23 %
Shareholdings
Promoter Holding	70.22 %	59.32 %	60.64 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	19.29 %	0.0	-0.03 %
Change in Mutual Fund Holding (3 Yrs)	1.59 %	-6.64 %	6.06 %

Business

	Unichem Lab	Dishman Carbogen Amc	Biocon
Product Wise Break-Up	Product Wise Break-Up Formulations 88.93 Bulk Chemicals 11.07 Cholesterol & Vit D Analogues 0 Quats & Generics 0 NCE APIs & Intermediates 0 Marketable Molecules 0 0 Generics 0 Novel 0 Biosimilars 0 Syngene (Research Services) 0 Branded Formulations 0 Biologics 0	Product Wise Break-Up Generics 0 Quats & Generics 4.4 Novel 0 Branded Formulations 0 Cholesterol & Vit D Analogues 9.4 Syngene (Research Services) 0 Biologics 0 Biosimilars 0 Formulations 0 Bulk Chemicals 0 Marketable Molecules 0 Contract Research & Contract Manufacturing (CRAMS) 77.7 API 8.5	Product Wise Break-Up Generics 17.41 Quats & Generics 0 Novel 0 Branded Formulations 0 Cholesterol & Vit D Analogues 0 Syngene (Research Services) 21.13 Biologics 0 Biosimilars 61.46 Formulations 0 Bulk Chemicals 0 Marketable Molecules 0 0 NCE APIs & Intermediates 0
Location Wise Break-Up	Location Wise Break-Up USA 60.32 India 2.47 Rest of the World 0 Ireland 0 Others 37.21	Location Wise Break-Up USA 0 India 1.71 Rest of the World 98.29 Ireland 0	Location Wise Break-Up USA 37.08 India 14.98 Rest of the World 37.4 Ireland 10.55